The annual Phillip and Ruth Hettleman Prizes for Artist … Continued
Greg G. Wang, PhD, and UNC researchers recently identified a gene termed PHF19 to be critically involved in the development and progression of multiple myeloma, and also provided proof-of-principle evidence supporting pharmacological targeting of this pathway for therapeutics of this common hematological cancer.
This paper describes a ground-breaking multi-omics technology to discover drivers of proliferative and invasive breast tumors.
Q & A with Suzanne Barbour by Carolina Garduate School Magazine
The lab of Aziz Sancar, MD, PhD, published a paper in the Journal of Biological Chemistry that could inform the creation of ‘chronochemotherapies’
$3-million instrument will bring exciting new capabilities to researchers across the university and others in the RTP area. The Talos Artica will be the centerpiece of the new cryoEM core facility, directed by Joshua Strauss, PhD.
The lab of William Marzluff, PhD, UNC Kenan Distinguished Professor of Biochemistry & Biophysics will collaborate with Cell Microsystems on gene editing projects to speed up the use of CRISPR workflows in lab experiments.
In a study in Nature Communications, Pengda Liu, PhD, Shelton Earp, MD, and their collaborators reported discoveries about a key signaling pathway that can be hyperactive in kidney cancer.
Liu was one of 28 scientists who were awarded V Scholar Grants in 2018 by the V Foundation for Cancer Research. The two-year, $200,000 grants are designed to identify and advance innovative young scientists who are establishing their research careers.
UNC researchers including Leslie Parise, PhD and doctoral student Alex Chung have designed a novel way to attack an aggressive breast cancer. By working with a drug development company, they hope their laboratory discovery will translate to a new treatment combination in the clinic in the future.